Metastatic Esophagogastric Cancer clinical trials

Explore recruiting metastatic esophagogastric cancer clinical trials.

Recruiting metastatic esophagogastric cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Esophagogastric Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and Preliminary Clinical Efficacy of MT-302 with CapOx based regimens in metastatic esophagogastric cancer (SPaCE-MT)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Metastatic Esophagogastric Cancer trials by city

Metastatic Esophagogastric Cancer in Toronto Metastatic Esophagogastric Cancer in Vancouver Metastatic Esophagogastric Cancer in Montreal Metastatic Esophagogastric Cancer in Calgary Metastatic Esophagogastric Cancer in Edmonton Metastatic Esophagogastric Cancer in Ottawa Metastatic Esophagogastric Cancer in Winnipeg Metastatic Esophagogastric Cancer in Quebec City Metastatic Esophagogastric Cancer in Hamilton Metastatic Esophagogastric Cancer in Kitchener Metastatic Esophagogastric Cancer in London Metastatic Esophagogastric Cancer in Halifax Metastatic Esophagogastric Cancer in New York Metastatic Esophagogastric Cancer in Los Angeles Metastatic Esophagogastric Cancer in Chicago Metastatic Esophagogastric Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease